It’s Not Over Yet For PTC Therapeutics Inc (NASDAQ: PTCT)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

PTC Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of PTC Therapeutics Inc is $4.23B. A total of 0.84 million shares were traded on the day, compared to an average of 711.89K shares.

In the most recent transaction, Boulding Mark Elliott sold 68,039 shares of PTCT for 53.09 per share on Mar 10 ’25. After the transaction, the EXEC. VP AND CLO now owns 103,901 company shares. In a previous transaction on Mar 11 ’25, Boulding Mark Elliott sold 7,381 shares at 53.02 per share. PTCT shares that EXEC. VP AND CLO owns now total 103,901.

Among the insiders who bought shares, Boulding Mark Elliott acquired of 15,521 shares on Mar 12 ’25 at a per-share price of $53.30. In another insider transaction, Boulding Mark Elliott bought 7,381 shares at $53.02 per share on Mar 11 ’25.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PTCT has a high of $55.60 and a low of $24.00.

As of this writing, PTCT has an earnings estimate of -$0.79 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.26 per share and a lower estimate of -$1.31.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PTCT’s latest balance sheet shows that the firm has $773.38M in Cash & Short Term Investments as of fiscal 2021. There were $1.27B in debt and $509.35M in liabilities at the time. Its Book Value Per Share was -$14.13, while its Total Shareholder’s Equity was $1.44M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Buy with a score of 3.81.

Most Popular

Related Posts